RISDIPLAM | RISDIPLAM | ATC M09AX10
MUSCULO-SKELETAL TREATMENT OF SPINAL MUSCULAR ATROPHY (SMA) A SURVIVAL OF MOTOR NEURON 2 (SMN2)-DIRECTED RNA SPLICING MODIFIER | ORAL | Tmax 2.5 HOUR VD 409.5 LITER (65 KILOGRAM) PPB 11 PERCENT Cl 2.1 LITER / HOUR HT 50 HOUR | MRNA | Unknown more at DrugCentral | EMA ANSM (in French) Inxight Drugs Dailymed Drugs.com SIDER side effects Chemical Probes Portal ChEMBL BindingDB DrugBank |